Current position:Home >Product >
R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin(695162-89-1)
- Name: R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- Synonyms:SF110017;R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d;R-3,3'-Bis(4-nitrophenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate;(R)-3,3'-Bis(4-nitrophenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate;R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-4-Hydroxy-2,6-bis(4-nitrophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;(11bR)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxidedinaphtho[ 2,1-d:1',2'-f][1,3,2]dioxaphosphepin;Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 4-hydroxy-2,6-bis(4-nitrophenyl)-, 4-oxide, (11bR)-;(11bR)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxidedinaphtho[ 2,1-d:1',2'-f][1,3,2]dioxaphosphepin,98%e.e.;(11bR)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
- Molecular Formula:C32H19N2O8P
- Molecular Weight:590.48
- CAS Registry Number:695162-89-1
- EINECS:
- Melting Point:223.5-249.0 °C (decomp)
- Water Solubility:
Other Product
- 99324-91-1/1-METHYLAMINOCYCLOPROPANE-1-CARBOXYLIC ACID HYDROCHLORIDE
- 99780-97-9/3-BOC-AMINO-PYRROLIDIN-2-ONE
- 168772-32-5/1-Oxa-4-azaspiro[4.5]decane-4-carboxylic acid, 3-formyl-, 1,1-dimethylethyl ester, (3S)-
- 878111-16-1/S-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- 1073375-73-1/3-Pyrrolidineethanol,-1-(phenylmethyl)-,(3S)-
- 878111-18-3/S-4-oxide-4-hydroxy-2,6-bis(2,4,6-triMethylphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- 281207-01-0/Chiral Bicyclic Guanidine(CBG11)
- 1157989-25-7/S-3,3'-Bis(triphenylsilyl)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate
- 158530-73-5/Chiral Bicyclic Guanidine(CBG12)
- 1217901-32-0/S-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 1046805-74-6/Chiral Guanidinium (CGN10)
- 1170736-59-0/S-3,3'-Bis(3,5-bis(methyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 1116115-22-0/Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium Slat
- 946074-05-1/S-2-[bis[3,5-bis(trifluoroMethyl)phenyl] [(triethylsilyl)oxy]Methyl]-Pyrrolidine
- 220841-46-3/Chiral Guanidinium (CGN12)
- 1048692-50-7/S-1-(3,5-bis(trifluoroMethyl)phenyl)-3-(1-(di MethylaMino)-3-Methylbutan-2-yl)thiourea
- 253597-19-2/5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid
- 695162-89-1/R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- 695162-87-9/R-4-oxide-4-hydroxy-2,6-bis(2,4,6-triMethylphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- 361342-55-4/R- 4-oxide-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- 33300-19-5/Cyclic-3-(1,2-ethanediylacetal)-17beta-cyano-17alpha-hydroxy-estra-5(10),9(11)-dien-3-one
- 861909-30-0/R-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 1065214-95-0/R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 861909-53-7/R-3,3'-Bis(3,5-bis(methyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 922711-75-9/R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 1041672-46-1/1,3,5-Triazin-2(1H)-one, 4-amino-1-(3,5-di-O-acetyl-2-deoxy-a-D-erythro-pentofuranosyl)-
- 1242066-20-1/R-3,3'-bis(1-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 1011465-24-9/R-3,3'-bis((3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- 1100289-57-3/R-2-[diphenyl[(triethylsilyl)oxy]Methyl]-Pyrrolidine
- 1096162-95-6/N-(2,2-Dimethyl-1-pyrrolidin-1-ylmethyl-propyl)-4-methyl-benzenesulfonamide